2nd Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVARTIS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases, Issues related to COVID-19 treatment

LobbyistCovered position, as disclosed
EMILY FELDER —

Contacted: State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE

Health Issues HCR

Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases, Issues related to COVID-19

LobbyistCovered position, as disclosed
NADEAM ELSHAMI —
MARC LAMPKIN —
BRIAN MCKEON —
RADHA MOHAN —
ZACHARY PFISTER —
BRIAN WILD —

Contacted: State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE

Veterans VET

Opportunities for health care collaboration

LobbyistCovered position, as disclosed
ARACELI GUTIERREZ —
ZACHARY PFISTER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); State, Dept of (DOS)

Immigration IMM

Issues related to visas

LobbyistCovered position, as disclosed
DOUGLAS MAGUIRE New —

Contacted: SENATE; Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; State, Dept of (DOS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.